Fireside Chat, Interview, Conference Presentation
a16z Podcast | The Business of Healthcare
- Future healthcare innovations are expected to prioritize decreasing costs and increasing care quality, driven by technology that addresses the current inability to scale proven interventions for conditions like type two diabetes.
- The industry will shift toward value-based contracts and outcomes pricing, supported by a macro tailwind from CMS and private sector initiatives to move away from purely transactional models.
- Organizations aim to manage outcomes by analyzing data nightly to provide coaches with personalized suggestions, ensuring non-transactional work is automated while using technology to scale human interventions efficiently.
- Growth strategies include contracting with health plan partners to operationalize programs, signing agreements for approximately 100,000 lives, and leveraging a large longitudinal dataset to measure every transaction.
- Revenue models are projected to involve upfront enrollment fees to cover costs, combined with per-member-per-month (PMPM) fees and incentives tied to clinical success.
- Strategic planning must account for the slower pace of change in healthcare, requiring collaboration with existing stakeholders rather than external shortcuts to build trust and achieve scale.
- Success is contingent on serving entities other than the patient as the primary buyer, with the organization aiming to establish specific chronic disease protocols as the standard of care, similar to the adoption of statins.
- Risks include the shrinking window for pharmaceutical patents, the difficulty of commercialization due to existing industry silos, and the necessity of peer-reviewed trials to secure reimbursement and adoption by medical director communities.
- Consumer engagement is expected to evolve with increased comfort in web and mobile interactions, while higher deductible plans continue to push companies and individuals toward more efficient, value-driven care consumption.